FDA Revisits Rules on Drug and Device Communication: Will the Agency Relax Existing Industry-Opposed Restrictions? [electronic resource]
Publication details: P & T : a peer-reviewed journal for formulary management Mar 2017Description: 173-204 p. digitalISSN:- 1052-1372
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.